DJBL treatment in patients with obesity and T2D resulted in a hemoglobin A1c (HbA1c) decrease of 1.3%, total weight loss of 18.9%, and excess weight loss of 36.9% with increases in GLP-1 and PYY (12). Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.